Summary
- Revenue
- TBPH current annual revenue is $107.46M, up +66.92% year-over-year
- Next Earnings
- As of today, the next earnings release for TBPH has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Theravance Biopharma Inc |
| Ticker | NASDAQ: TBPH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | theravance.com |
| Employees | 90 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $107.46M | ||
| Revenue, 1Y Change | +66.92% | |
| $2.06 | ||
| EPS, 1Y Change | +278.00% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $2.06 | ||
| EPS Estimate | $0.21 | N/A |
| EPS Est. Change | -89.79% | N/A |
| $107.46M | ||
| Revenue Estimate | $89.92M | N/A |
| Revenue Est. Change | -16.33% | N/A |
| Current Price | - | |
| Price Target | $17.00 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.42 | -$1.16 | -172.86% | |
| $0.12 | $2.06 | +1,613.25% | |
| $0.21 | N/A | -89.79% | |
| $1.28 | N/A | -37.98% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $62.58M | $64.38M | +2.89% | |
| $111.33M | $107.46M | -3.47% | |
| $89.92M | N/A | -16.33% | |
| $84.80M | N/A | -21.09% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $107.46M | ||
| $2.06 | ||
| $0.00 | ||
| 0.00% | ||
| -$3.60M | ||
| -3.35% | ||
| $105.90M | ||
| 98.54% | ||
| -$7.73M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.11 | ||
| 10.93 | ||
| 10.93 | ||
| - | ||
| 5 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $296.72M | ||
| $315.36M | ||
| $485.57M | ||
| $418.46M | ||
| $188.85M | ||
| $38.30M | ||
| $31.76M | ||
| $10.95M | ||
| $2.57M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.57M | ||
| $3.60M | ||
| $5.52M | ||
| $0.00 | ||
| $5.64M | ||
| $0.00 | ||
| $23.35M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $238.54M | ||
| -$105.28M | ||
| -$3.25M | ||
| $42.00K | ||
| $238.50M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Jones Trading | → | |
| BTIG | → | |
| B. Riley Securities | → | |
| TD Cowen | → | |
| BTIG | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TBPH
FAQ
- What is the ticker symbol for Theravance Biopharma Inc?
- The ticker symbol for Theravance Biopharma Inc is NASDAQ:TBPH
- Does Theravance Biopharma Inc pay dividends?
- No, Theravance Biopharma Inc does not pay dividends
- What sector is Theravance Biopharma Inc in?
- Theravance Biopharma Inc is in the Healthcare sector
- What industry is Theravance Biopharma Inc in?
- Theravance Biopharma Inc is in the Biotechnology industry
- What country is Theravance Biopharma Inc based in?
- Theravance Biopharma Inc is headquartered in United States
- When did Theravance Biopharma Inc go public?
- Theravance Biopharma Inc initial public offering (IPO) was on May 16, 2014
- Is Theravance Biopharma Inc in the S&P 500?
- No, Theravance Biopharma Inc is not included in the S&P 500 index
- Is Theravance Biopharma Inc in the NASDAQ 100?
- No, Theravance Biopharma Inc is not included in the NASDAQ 100 index
- Is Theravance Biopharma Inc in the Dow Jones?
- No, Theravance Biopharma Inc is not included in the Dow Jones index
- When was Theravance Biopharma Inc last earnings report?
- Theravance Biopharma Inc's most recent earnings report was on November 10, 2026
- When does Theravance Biopharma Inc report earnings?
- The date for Theravance Biopharma Inc's next earnings report has not been announced yet
Data Sources & References
- TBPH Official Website www.theravance.com
- TBPH Profile on Yahoo Finance finance.yahoo.com/quote/TBPH
- TBPH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tbph
